The federal government is suing some big pharmacy benefit managers, or PBMs, over a system of drug rebates that regulators ...

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

For years, these cities and states have insisted on a cut—if not all—of the rebates that these pharmacy benefit managers ... make two claims: that insulin prices are unreasonably high and ...

The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.

Patients remain sidelined in this scheme, as their cost-sharing is based on the list price, not the discounted rate. PBMs have become powerful gatekeepers in the prescription drug market ...

The Federal Trade Commission is suing the titans of the pharmacy benefit manager industry for anticompetitive practices and ...

The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.